Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of$0.05 per share. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +20.00$0.03 per share when it actually produced earnings of $0.02, delivering a surprise of -33.33%.Over the last four quarters, th ...